BNP Paribas Asset Management’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$89.7K Sell
8,611
-157,321
-95% -$1.76M ﹤0.01% 1584
2026
Q1
$1.97M Buy
165,932
+505
+0.3% +$5.17K ﹤0.01% 1075
2025
Q4
$1.65M Buy
165,427
+164,427
+16,443% +$1.57M ﹤0.01% 1096
2025
Q3
$9K Buy
1,000
+152
+18% +$1.41K ﹤0.01% 1655
2025
Q2
$8K Buy
+848
New +$7.48K ﹤0.01% 1831

Other funds holding AHCO

BNP Paribas Asset Management's AHCO Position: Q2 2026 in Review

BNP Paribas Asset Management reduced its AdaptHealth (AHCO) stake by 95% in Q2 2026, selling an estimated $1.76M and leaving 8,611 shares worth $89.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1584.

BNP Paribas Asset Management first reported a position in AHCO in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.97M in Q1 2026. 239 funds tracked by Wall St. Rank hold AHCO as of Q2 2026.

  • BNP Paribas Asset Management held 8,611 shares of AdaptHealth worth $89.7K as of Q2 2026.
  • BNP Paribas Asset Management sold 157,321 AdaptHealth shares in Q2 2026, an estimated $1.76M.
  • AdaptHealth made up ﹤0.01% of BNP Paribas Asset Management's portfolio in Q2 2026, its #1584 holding.
  • BNP Paribas Asset Management first reported a position in AdaptHealth in Q2 2025 and has held it in 5 quarters since.
  • BNP Paribas Asset Management's AdaptHealth position peaked at $1.97M in Q1 2026.
  • 239 funds tracked by Wall St. Rank held AdaptHealth as of Q2 2026.

Based on BNP Paribas Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.